Literature DB >> 9039545

Diagnosis of tuberculosis and other diseases caused by mycobacteria.

M Salfinger1.   

Abstract

The adequate diagnosis and treatment of tuberculosis depends on many events, including rapid pathogen detection, patient isolation, species identification, and drug susceptibility testing. Well trained staff, using state-of-the-art technology, are necessary in the mycobacteriology laboratory to produce timely results that are necessary for the patients' care and public health measures. Mycobacteriology laboratories still play a pivotal role in the control of tuberculosis, which is especially true in view of the spread of multidrug-resistant tuberculosis. One way to optimize diagnostic efforts in spite of limited financial resources might be to sort and allocate specimens according to a system of priorities, e.g., diagnostic versus follow-up specimens. A "fast track" program for tuberculosis testing, which should be established as part of a dynamic diagnostic network, should focus on the highly infectious patient population. Collaboration between clinicians and mycobacteriologists remains the basis of dynamic diagnostic teamwork. Immediate screening of smears for acid-fast-bacilli in patients suspected of tuberculosis, followed by immediate processing of smear-positive specimens using modern mycobacteriological technology, should be given high priority. Diagnosis of disease due to nontuberculous mycobacteria can be difficult. Nontuberculous mycobacteria are commonly found in nature, and assessment as to whether a nontuberculous mycobacterium isolate is clinically significant can be a difficult task.

Entities:  

Mesh:

Year:  1997        PMID: 9039545     DOI: 10.1007/bf02113517

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  Diagnosis and treatment of disease caused by nontuberculous mycobacteria.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1990-10

Review 2.  The role of the microbiology laboratory in diagnosing mycobacterial diseases.

Authors:  M Salfinger; A J Morris
Journal:  Am J Clin Pathol       Date:  1994-04       Impact factor: 2.493

Review 3.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

4.  Tuberculosis diagnosed at death in the United States.

Authors:  H L Rieder; G D Kelly; A B Bloch; G M Cauthen; D E Snider
Journal:  Chest       Date:  1991-09       Impact factor: 9.410

  4 in total
  3 in total

1.  Identifying sputum specimens of high priority for examination by enhanced mycobacterial detection, identification, and susceptibility systems (EMDISS) to promote the rapid diagnosis of infectious pulmonary tuberculosis.

Authors:  R Freeman; J Magee; A Barrett
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

2.  Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.

Authors:  Miguel Viveiros; Clara Leandro; Liliana Rodrigues; Josefina Almeida; Rosário Bettencourt; Isabel Couto; Lurdes Carrilho; José Diogo; Ana Fonseca; Luís Lito; João Lopes; Teresa Pacheco; Mariana Pessanha; Judite Quirim; Luísa Sancho; Max Salfinger; Leonard Amaral
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Performance of the BD ProbeTec ET direct detection assay for the analysis of Mycobacterium tuberculosis in respiratory and non-respiratory clinical specimens.

Authors:  Ali M Somily; Hanan A Habib; Mohammed S Sarwar; Nourah Z Al-Beeshi; Rawa M Alohali; Zahid A Shakoor
Journal:  J Taibah Univ Med Sci       Date:  2016-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.